RetinaDigest

For primary rhegmatogenous retinal detachment (RRD) in phakic eyes, phacovitrectomy provides anatomical outcomes comparable to vitrectomy alone, with any observed visual advantage largely attributable to lens removal rather than a superior retinal treatment effect.

A retrospective study in the Medicare population (2011-2021) revealed a decline in scleral buckle use, specific patient risk factors for complex RD, and significant geographic and gender disparities among retinal surgeons and patient access to care.

Swept-source OCTA non-perfusion area (NPA) is associated with diabetic nephropathy (DN) and its severity, potentially serving as a non-invasive ophthalmic biomarker for renal function in patients with diabetes.

A meta-analysis revealed substantial US prevalence of AMD, DR, DME, and RVO in 2022, with significant disparities by gender, race/ethnicity, and region, highlighting a considerable healthcare burden.

Aflibercept 8 mg achieved visual and anatomic outcomes comparable to aflibercept 2 mg with extended dosing intervals in treatment-naïve nAMD, regardless of baseline disease severity.

Switching refractory Caucasian PCV patients to faricimab resulted in anatomical and functional stability in the majority, with good tolerability and potential for injection interval extension.

Abstract not available — see full article for details.

Patients experiencing acute ischemic ocular events (IOEs) like retinal artery occlusion or amaurosis fugax are at significant risk for subsequent ischemic stroke (IS) or transient ischemic attack (TIA), with older age, hypertension, cardiovascular disease, and carotid artery stenosis being key risk factors.

Abstract not available — see full article for details.

Abstract not available — see full article for details.

Early and aggressive immunosuppressive therapy can achieve complete reperfusion of occluded retinal arterioles in pediatric Susac syndrome, even when the full clinical triad is absent.

Abstract not available — see full article for details.

In pediatric high myopes, 2-year axial length (AL) changes, combined with baseline AL, accurately predict long-term myopic maculopathy (MM) progression, with an optimal AL change rate cutoff of 0.325 mm/year.

Abstract not available — see full article for details.

A multinational task force developed standardized imaging measures using multimodal imaging to assess disease activity (active, inactive, or equivocal) in non-infectious posterior uveitis (NIPU).

Non-infectious posterior and panuveitides (NIPUs) comprise a heterogeneous group of inflammatory disorders of the outer retina and choroid, historically referred to as "white dot syndromes." Recent consensus efforts by the Multimodal Imaging in Uveitis (MUV) Task Force have established standardized

Adalimumab effectively treats pediatric non-infectious uveitis (NIU), and escalating to weekly dosing significantly improves inflammation control and reduces relapse risk in refractory cases without compromising safety.

Abstract not available — see full article for details.

Low serum vitamin D levels are significantly associated with an increased risk of both infectious and non-infectious ocular inflammation, including specific subtypes relevant to retina specialists.

Patients with chronic central serous chorioretinopathy (cCSC) who achieved initial success with half-dose photodynamic therapy (PDT) showed superior long-term visual and anatomical outcomes compared to those with unsuccessful initial treatment. Notably, visual acuity stabilized in both groups after the first follow-up visit.

Abstract not available — see full article for details.